Mark Milazzo

1.5k total citations
16 papers, 328 citations indexed

About

Mark Milazzo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mark Milazzo has authored 16 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Mark Milazzo's work include HIV/AIDS Research and Interventions (11 papers), HIV Research and Treatment (8 papers) and HIV, Drug Use, Sexual Risk (4 papers). Mark Milazzo is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV Research and Treatment (8 papers) and HIV, Drug Use, Sexual Risk (4 papers). Mark Milazzo collaborates with scholars based in United States, Mozambique and Germany. Mark Milazzo's co-authors include Adam W. Armstrong, Brian K. Agan, Scott A. Wegner, Alina Burgi, Stephanie K. Brodine, Katherine Spooner, Mark R. Wallace, Susan Fraser, Nancy F. Crum and David L. Blazes and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Mark Milazzo

14 papers receiving 323 citations

Peers

Mark Milazzo
Warren Phipps United States
Pamela P. Gumbi South Africa
For Yue Tso United States
William E. Sanchez United States
Estela Luz Brazil
Hansjakob Furrer Switzerland
F. Guibal France
Mark Milazzo
Citations per year, relative to Mark Milazzo Mark Milazzo (= 1×) peers Nadia Zanchetta

Countries citing papers authored by Mark Milazzo

Since Specialization
Citations

This map shows the geographic impact of Mark Milazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Milazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Milazzo more than expected).

Fields of papers citing papers by Mark Milazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Milazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Milazzo. The network helps show where Mark Milazzo may publish in the future.

Co-authorship network of co-authors of Mark Milazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Milazzo. A scholar is included among the top collaborators of Mark Milazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Milazzo. Mark Milazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sing’oei, Valentine, John Owuoth, Qun Li, et al.. (2024). HIV prevalence and awareness among adults presenting for enrolment into a study of people at risk for HIV in Kisumu County, Western Kenya. PLoS ONE. 19(1). e0294860–e0294860. 4 indexed citations
2.
Bhatt, Nilesh, Mark Milazzo, Qun Li, et al.. (2024). HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study. BMC Public Health. 24(1). 2692–2692.
3.
Bedno, Sheryl A., Shilpa Hakre, Shannon Clark, et al.. (2023). Prospective screening for sexually transmitted infections among US service members with Chlamydia trachomatis or Neisseria gonorrhoeae infection. PLoS ONE. 18(1). e0280783–e0280783.
4.
Bhatt, Nilesh, Mark Milazzo, Trevor A. Crowell, et al.. (2021). Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study. PLoS ONE. 16(12). e0260126–e0260126. 2 indexed citations
5.
Eller, Leigh Anne, John Lawlor, Mark Milazzo, et al.. (2020). Determining hematological, biochemical and immunological reference values in healthy adults with high-risk for HIV acquisition in Mozambique. PLoS ONE. 15(4). e0232018–e0232018. 2 indexed citations
6.
Bhatt, Nilesh, Leigh Anne Eller, Qun Li, et al.. (2019). HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique. PLoS ONE. 14(9). e0221682–e0221682. 6 indexed citations
7.
Kijak, Gustavo H., Eric Sanders‐Buell, Anne Marie O’Sullivan, et al.. (2019). Next-generation sequencing of HIV-1 single genome amplicons. SHILAP Revista de lepidopterología. 17. 100080–100080. 7 indexed citations
8.
Billings, Erik, Gustavo H. Kijak, Eric Sanders‐Buell, et al.. (2019). New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(5). 578–584. 9 indexed citations
9.
Njoku, O S, Mark Manak, Robert J. O’Connell, et al.. (2016). An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria. PLoS ONE. 11(12). e0166711–e0166711. 2 indexed citations
10.
Manak, Mark, O S Njoku, Jennifer Malia, et al.. (2015). Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in Nigeria. Journal of Clinical Microbiology. 53(11). 3501–3506. 15 indexed citations
11.
Streeck, Hendrik, Richard Lu, Noor Beckwith, et al.. (2014). Emergence of Individual HIV-Specific CD8 T Cell Responses during Primary HIV-1 Infection Can Determine Long-Term Disease Outcome. Journal of Virology. 88(21). 12793–12801. 25 indexed citations
12.
Brown, Bruce K., Josephine H. Cox, Thomas C. VanCott, et al.. (2010). Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults. PLoS ONE. 5(11). e13849–e13849. 28 indexed citations
13.
Silverberg, Michael J., Scott A. Wegner, Mark Milazzo, et al.. (2006). Effectiveness of highly-active antiretroviral therapy by race/ethnicity. AIDS. 20(11). 1531–1538. 36 indexed citations
14.
Burgi, Alina, Stephanie K. Brodine, Scott A. Wegner, et al.. (2005). Incidence and risk factors for the occurrence of non‐AIDS‐defining cancers among human immunodeficiency virus‐infected individuals. Cancer. 104(7). 1505–1511. 167 indexed citations
15.
Renzullo, Philip O., Christian T. Bautista, Robin P. Garner, et al.. (2001). HIV-1 seroconversion in United States Army active duty personnel, 1985–1999. AIDS. 15(12). 1569–1574. 18 indexed citations
16.
Gardner, Lytt I., John F. Brundage, John G. McNeil, et al.. (1992). Predictors of HIV-1 Disease Progression in Early- and Late-Stage Patients. 5(8). 782???793–782???793. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026